Sarah Cannon Research Institute / Tennessee Oncology — Nashville, Tennessee

Public research footprint of Sarah Cannon Research Institute / Tennessee Oncology, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · RET-altered Non Small Cell Lung Cancer · Pancreas Cancer · Cancer of the Ovary

Recently updated registry entries

NCT04929223 — A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of… (Recruiting)
NCT04524871 — A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment… (Recruiting)
NCT05359861 — Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sarah Cannon Research Institute / Tennessee Oncology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.